Résumé de la déclaration
JPMorgan Chase & Co a déclaré une participation à l'acquisition dans DocMorris AG, publiée à SIX Exchange Regulation le 12.07.2026, pour un taux de droits de vote de 11.844%. Catégorie de l'annonce : Actionnaire unique.
Position déclarée
Position déclarée
11.844%
Droits de vote acquis
Catégorie
Actionnaire unique
Date de publication
12.07.2026
Ces chiffres sont des agrégats de déclarations publiques. Ils ne constituent pas un conseil en investissement.
Détail de la déclaration
JPMorgan Chase & Co a déclaré une participation dans DocMorris AG, publiée le 12.07.2026.
Conditions
With recommendations of the Disclosure Office dated 11 August 2016, 8 August 2019, 29 July 2022 and 11 August 2025, JPMorgan Chase & Co. was granted easing provisions from the obligation to disclose the direct shareholders according to Article 120 para. 1 FinMIA in conjunction with Article 11 lit. b and Article 22 para. 1 lit. e and para. 3 FinMIO-FINMA when disclosing holdings according to Article 18 para. 1 and 4 FinMIO-FINMA. However, collective investment schemes within the meaning of Article 18 para. 2 lit. a FinMIO-FINMA that hold individually hold 3% or more of the voting rights of the relevant issuer will be mentioned in the relevant disclosure notification. Any person shall, upon request and without proof of interest, receive information about the direct shareholders within the meaning of Article 11 lit. b and Article 22 para. 1 lit. e and para. 3 FinMIO-FINMA. Such requests must be addressed via email to the Disclosure Office: disclosure-office@six-group.com. The information will be provided within five trading days from receipt of the relevant request by JPMorgan Chase & Co and will be delivered in electronic format with a reference date not older than one month. The easing provisions are granted until 11 August 2028.
Source: SIX Exchange Regulation · Date de publication: 12.07.2026
Ces chiffres sont des agrégats de déclarations publiques. Ils ne constituent pas un conseil en investissement.